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Background: National community-based health worker (CBHW) programs often face challenges in ensuring that
these remote workers are adequately trained, equipped and supervised. As governments increasingly deploy
CBHWs to improve access to primary health care, there is an urgent need to assess how well health systems are
supporting CBHWs to provide high quality care.
Methods: This paper presents the results of a mixed-methods assessment of selected health systems supports
(supervision, drug supply, and job aids) for a national community case management (CCM) program for childhood
illness in Malawi during the first year of implementation. We collected data on the types and levels of drug supply
and supervision through a cross-sectional survey of a random sample of Health Surveillance Assistants (HSAs)
providing CCM services in six districts. We then conducted in-depth interviews and focus group discussions with
program managers and HSAs, respectively, to gain an understanding of the barriers and facilitating factors for
delivering health systems supports for CCM.
Results: Although the CCM training and job aid were well received by stakeholders, HSAs who participated in the
first CCM training sessions often waited up to 4 months before receiving their initial supply of drugs and first
supervision visits. One year after training began, 69% of HSAs had all essential CCM drugs in stock and only 38% of
HSAs reported a CCM supervision visit in the 3 months prior to the survey. Results of the qualitative assessment
indicated that drug supply was constrained by travel distance and stock outs at health facilities, and that the initial
supervision system relied on clinicians who were able to spend only limited time away from clinical duties.
Proactive district managers trained and enrolled HSAs’ routine supervisors to provide CCM supervision.
Conclusions: Malawi’s CCM program is promising, but health systems supports must be improved to ensure
consistent coverage and quality. Mixed-methods implementation research provided the Ministry of Health with
actionable feedback that it is using to adapt program policies and improve performance.
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The majority of low-income countries are not on track
to meet Millennium Development Goal 4 of achieving a
two-thirds reduction in child mortality by 2015, despite
improved global efforts in maternal and child health [1].
Coverage of key child health interventions, such as
artemisinin-combined therapies for malaria and antibio-
tics for pneumonia, remains low [2]. The WHO and
UNICEF promote integrated community case manage-
ment of childhood illnesses (CCM) as a strategy that
countries can adopt to improve coverage levels of these
key curative interventions [3]. CCM programs typically in-
clude the treatment of uncomplicated childhood illnesses
in communities by trained volunteer or lay health workers,
as well as timely referral for severe illnesses and counsel-
ing on health promotion and care seeking [4]. CCM has
proven effective at reducing child mortality rates in con-
trolled intervention trials and pilot programs [5-7], but
there are fewer examples of integrated CCM programs at
regional or national scale [8], especially in Africa [9].
Despite the growing interest in scaling-up CCM pro-
grams in many countries, implementing and sustaining
support for these programs remains a major challenge in
low-income settings and there has been little published
research investigating implementation of routine CCM
programs [10-12]. This has prompted calls for urgent re-
search that explores how CCM programs can be imple-
mented effectively [13-15].
CCM programs must be well supported by the health
system in order to function effectively and achieve the
desired impact on child health [4,16-18]. Following ini-
tial training in CCM, community-based health workers
(CBHWs) should receive regular supportive supervision
and consistent drug supplies, and be supported by effect-
ive job aids [10,17,18]. CBHWs providing CCM services
often have no previous clinical experience, are trained
for short periods of time, have low levels of education,
and are posted in isolated settings [18-22]. As a result,
supportive supervision, including observation of case
management and corrective feedback, and effective job
aids, are considered particularly important for ensuring
high quality care by CBHWs [23,24]. Disruptions in sup-
plies of essential drugs prevent CBHWs from providing
life saving treatments, and can also damage the credibil-
ity of CCM programs and CBHWs among community
members [10,25]. Lack of health system support contrib-
uted to the mixed results and decline of CBHW pro-
grams initiated following the Declaration of Alma Atta
[19,20], thus it is crucial that health systems supports for
CCM are addressed to ensure the success and sustain-
ability of newly introduced CCM programs.
This paper examines the implementation of training,
supervision, drug supply, and job aids during the scale-
up of a national CCM program in Malawi. Malawi, asmall low-income country in southeast Africa, was an
early adopter and implementer of CCM [8]. Malawi’s
under-five mortality rate is estimated at 92 per 1,000 live
births [1]. Although Malawi is considered on-track to
reach MDG 4, the country must further reduce the under-
five mortality rate by 20% to reach its MDG target [1]. In
2008, as a part of its child health strategy, Malawi’s Ministry
of Health (MOH) began training Health Surveillance
Assistants (HSAs), an existing cadre of paid CBHWs, to
treat uncomplicated cases of malaria, pneumonia, and
diarrhea in the community [26,27]. The objectives of this
paper are to: 1) describe the types and levels of selected
health systems supports provided to HSAs performing
CCM in Malawi; and, 2) identify factors that constrain and
facilitate the delivery of health systems supports.Methods
Although the concept of health systems supports for
CCM can be broadly conceptualized to include many fac-
tors, this study focuses on the primary concerns of the
MOH in Malawi during early implementation of the CCM
program: 1) implementation of training; 2) supervision;
3) drug supply; and 4) job aids. The focus of the study
is based on the specific context of the CCM program
in Malawi; other health systems factors, such as recruit-
ment standards, compensation and incentives, training con-
tent, and engagement of the community, are tied to policies
for the entire HSA cadre, rather than the introduction of
CCM to HSAs’ activities, and are not addressed here.Study setting
Health Surveillance Assistants are a cadre of CBHW in
Malawi that was originally established in the 1960s to
support smallpox vaccinations [28]. HSAs are formal
non-clinician health workers who are salaried by the
government, are required to have 10 to 12 years of edu-
cation, and undergo a 10-week basic training [29]. The
government recruited over 5,000 new HSAs between
2002 and 2010 through grants from the Global Fund to
Fight AIDS, Tuberculosis, and Malaria. HSAs now serve
a catchment area of approximately 1,000 people and
their main functions are to provide health education and
sanitation within the communities where they are posted
[29]. Although some HSAs serve urban areas, the major-
ity are posted to rural communities and are supervised
by Assistant Environmental Health officers (AEHOs)–non-
clinicians under the MOH’s Preventive Health Section
and based at health facilities–and Senior HSAs–HSAs
posted in communities who have been promoted to a
supervisory role. HSAs are expected to receive a supervi-
sion visit from an AEHO or Senior HSA in their commu-








Figure 1 Map of study districts.
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September 2008 in ten districts receiving technical sup-
port and funding from WHO and UNICEF for early
CCM implementation. Selected HSAs received six days
of training to treat uncomplicated cases of malaria,
pneumonia, and diarrhea following a job aid, known as
the sick child recording form, with an algorithm adapted
from the Integrated Management of Childhood Illness
(IMCI) guidelines [30]. The six-day trainings were led
centrally at the district level by trained clinicians from dis-
trict hospitals. Implementation plans specified that HSAs
should receive a wooden drug box, with a lock and initial
drug supplies, on the last day of training. Six of the ten
early districts with the strongest levels of CCM imple-
mentation (based on the number of HSAs trained and
equipped to operate village health clinics) were selected
for inclusion in this early evaluation of the program. The
six districts represent all three of Malawi’s regions–two
from the southern region, three in the central region, and
one in the northern region (see Figure 1). Facility-based
health services in these districts are provided by the
Malawi MOH, which provides services free of charge, and
the Christian Health Association of Malawi (CHAM), a
non-profit organization that charges user fees for most
services and drugs provided at its clinics. Additional
details about the HSA program and components of the
CCM package are available elsewhere [29].
Study design and data collection
This study was conducted in partnership with the Ministry
of Health as a part of an independent evaluation of the
Catalytic Initiative, led by the Johns Hopkins University
Institute for International Programs and the Malawi
National Statistics Office. The design followed an
explanatory-sequential approach [31] by collecting quanti-
tative data on the types and levels of health systems sup-
ports, followed by a qualitative study to gain greater
understanding of the support systems, barriers, and facili-
tating factors. Quantitative data on the quality of care and
the types and levels of health system supports were col-
lected from a random sample of HSAs operating village
health clinics in the six selected districts through a cross-
sectional survey, with results on quality of care available
elsewhere [32]. Data were collected by three-person survey
teams, composed of CCM trainers from the Ministry of
Health, trained and supervised by Johns Hopkins research-
ers and MOH managers. Briefly, the teams visited sampled
HSAs in the rural posts where they conduct village health
clinics to observe sick child consultations, record the avail-
ability of drugs, and to ask the HSA to recall the supervi-
sion visits he or she received and any drug stock outs in
the past 3 months using a standard questionnaire. In order
to minimize bias in data collection, survey teams were sent
to different districts than those in which they worked. Asample size of 132 HSAs was calculated to allow obser-
vation of 369 sick child consultations and estimate
the proportion of sick children correctly managed with
+/− 6%, assuming 95% confidence and a design effect of
1.5 [32]. Data collection took place during a four-week
period in October and November 2009, approximately
one year after CCM implementation began. The indica-
tors for drugs and equipment were selected based on the
functional requirements of the village health clinic as indi-
cated by the national CCM treatment algorithm [27] and
were calculated for the overall sample and each district
using Stata 10 [33]. Differences between districts were
tested using Fischer’s exact test for proportions and the
Kruskall-Wallis rank-sum test for interval indicators.
At the time of the study there had been no systematic
documentation of how the CCM program was being
implemented at district level to support interpretation of
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interviews and focus groups to obtain information on
program implementation strategies and challenges, fo-
cusing on the areas of CCM training, supervision, job aids,
and drug supply. These qualitative data were collected over
a four-week period in November and December 2009 by
two independent Malawian researchers and a Johns
Hopkins researcher, with permission and introductions
from Ministry of Health officials. A pilot of the qualitative
protocol and interview guides, conducted in a district
excluded from the study, identified the relevant personnel
in each district to include the District Health Officer, IMCI
Coordinator, Administrator, Environmental Health Officer,
Assistant Environmental Health Officers, Health Center
Clinicians, and Senior HSAs. Although the study team
interviewed the IMCI Coordinators--the manager with pri-
mary responsibility for the CCM program at district level--
for all six districts included in the survey, study timing did
not permit visits to all districts. Four of the six districts–
Lilongwe, Kasungu, Phalombe, and Ntcheu--representing
high- and low-performing districts in terms of supervision
and drug supply based on the preliminary results from the
quantitative survey, were selected for in-depth interviews
with other health personnel. In-depth investigation in these
four districts was expected to reveal variations in imple-
mentation strategies and challenges between districts.
During visits to each of the four districts, the study team
attempted to interview each of the individuals occupying
these positions. Focus groups with HSAs operating village
health clinics were also conducted in the four selected dis-
tricts. Interview and focus group methods are described in
detail elsewhere [34]. Three members of the research team
coded all transcripts using a standard coding index. Ana-
lysis procedures for exploring themes in the data included
summarizing health system strategies (e.g., drug supply
delivery method) for each district, developing implementa-
tion timelines, and placing coded data in charts by district
and respondent cadre. Reported constraints for delivering
health system supports were analyzed for underlying fac-
tors using root cause analysis techniques [35]. Data from
the quantitative and qualitative components of the study
were triangulated, and associations between qualitative
data on health systems strategies and quantitative out-
comes were assessed for using Fischer’s exact test. Prelim-
inary results were reviewed with stakeholders at national
and district level, including representatives of DHMTs in
all participating districts. This study was approved by the
Institutional Review Boards at the Johns Hopkins Bloomberg
School of Public Health and the Malawi National Health
Sciences Research Committee.
Results
A total of 131 HSAs were surveyed for drug supply, equip-
ment, and supervision levels (Table 1). The majority ofHSAs in the survey were male, had completed second-
ary school, and had spent less than five years in the
community where they were working. Based on review
of available registers, the median number of sick chil-
dren treated by each HSA in September 2009 was 41.
The qualitative sample included 4 focus group discus-
sions with HSAs and interviews with 9 supervisors and
clinicians and 20 district-level managers (Table 2). The
results section is presented by thematic content (train-
ing and establishing supports, drug supply, supervision,
and job aids) and draws on both the quantitative and
qualitative results.Training and establishing supports for CCM
Following national workshops to adapt the CCM algo-
rithm and train trainers in September 2008, the ten dis-
tricts selected for early implementation started training
with HSAs posted to the most “hard-to-reach” areas.
Hard-to-reach areas are defined by each DHMT (usually
the Environmental Health Officer), based on the general
criterion offered by the MOH of approximately 7 km or
farther from a health facility. DHMTs were responsible
for determining the pace of training sessions and rollout
of CCM in their district, with support and feedback from
WHO and UNICEF offices. In qualitative assessments,
managers from several districts indicated that they were
purposefully introducing the program slowly in order to
identify and correct problems with health system sup-
ports. As said by one district IMCI Coordinator: “It isn’t
possible to just train everybody because we also have to
consider the quality of the services they will be deliver-
ing . . . We suggest . . . to first sort out supervision and
other logistics.”
Despite awareness of the need for supervision and
other health system supports among some managers,
these inputs and processes were still under development
throughout the first year of the CCM program. Following
the 6-day CCM training, HSAs were to begin operating
their village health clinics (VHCs) when they received
their wooden drug box and initial supply of drugs. The ini-
tial drug boxes were delivered directly to the HSAs’ post
or the nearest health center from the district level. In most
districts, there were substantial delays between the time
that the HSAs completed training and when they received
their drug box (Figure 2). Four districts (Lilongwe,
Kasungu, Phalombe, and Mzimba) each had 40 or more
HSAs trained by November 2008 who did not receive
drug boxes until March 2009. After the delivery of the ini-
tial drug supply with the drug box, the MOH’s strategy
was to integrate CCM drug resupplies into the routine
drug supply system. HSAs disbursed the same drugs, in
the same packaging, as health facilities, and were to collect
resupplies of drugs from their nearest health facility, which
Table 1 Descriptive statistics for the sample of Health Surveillance Assistants
District All districts Kasungu Lilongwe Mzimba Nsanje Ntcheu Phalombe
Age
20 to 24 13 (9.9%) 2 (9.5%) 1 (4.6%) 1 (4.6%) 3 (13.6%) 4 (18.2%) 2 (9.1%)
25 to 29 37 (28.2%) 8 (38.1%) 3 (13.6%) 5 (22.7%) 5 (22.7%) 9 (40.9%) 7 (31.8%)
30 to 39 57 (43.5%) 10 (47.6%) 10 (45.5%) 7 (31.8%) 12 (54.6%) 8 (36.4%) 10 (45.5%)
40 to 49 19 (14.5%) 1 (4.8%) 5 (22.7%) 8 (36.4%) 1 (4.6%) 1 (4.6%) 3 (13.6%)
50 and above 5 (3.8%) 0 3 (13.6%) 1 (4.6%) 1 (4.6%) 0 0
Sex
Male 106 (80.9%) 17 (80.9%) 18 (81.8%) 18 (81.8%) 16 (72.7%) 15 (68.2%) 22 (100.0%)
Female 25 (19.1%) 4 (19.1%) 4 (18.2%) 4 (18.2%) 6 (27.3%) 7 (31.8%) 0
Recruitment year
Before 1990 2 (1.5%) 0 1 (4.6%) 1 (4.6%) 0 0 0
1990 to 1999 52 (39.7%) 8 (38.1%) 11 (50.0%) 13 (59.1%) 7 (31.8%) 5 (22.7%) 8 (36.4%)
2000 to 2004 13 (9.9%) 0 2 (9.1%) 1 (4.6%) 5 (22.7%) 0 5 (22.7%)
2005 to 2009 64 (48.9%) 13 (61.9%) 8 (36.4%) 7 (31.8%) 10 (45.5%) 17 (77.3%) 9 (40.9%)
Education
Primary school 5 (3.8%) 0 2 (9.1%) 2 (9.1%) 0 0 1 (4.6%)
Form Two 45 (34.4%) 6 (28.6%) 11 (50.0%) 6 (27.3%) 13 (59.1%) 4 (18.2%) 5 (22.7%)
Form Four 81 (61.8%) 15 (71.4%) 9 (40.9%) 14 (63.6%) 9 (40.9%) 18 (81.8%) 16 (72.7%)
Years in community*
Less than 1 year 19 (14.8%) 3 (14.3%) 3 (14.3%) 2 (9.1%) 7 (35.0%) 2 (9.1%) 2 (9.1%)
1 to 5 years 75 (58.6%) 14 (66.7%) 12 (57.2%) 15 (68.2%) 7 (35.0%) 14 (63.6%) 13 (59.1%)
5 to 10 years 22 (17.9%) 2 (9.5%) 4 (19.1%) 4 (18.2%) 2 (10.0%) 5 (22.7%) 5 (22.7%)
More than 10 years 8 (6.3%) 2 (9.5%) 2 (9.5%) 1 (4.6%) 0 1 (4.6%) 2 (9.1%)
From community 4 (3.1%) 0 0 0 4 (18.2%) 0 0
Median number of CCM cases per
HSA in September, 2009 (IQR)
41 (54) 50 (65) 48 (45) 25 (52) 29 (54) 51 (48) 34 (64)
*n=128; 3 missing.
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medical stores.
During the CCM program’s first year, the national
IMCI office had not yet provided guidance on supervi-
sion protocols to districts, such as standardized check-
lists or guidelines for activities to be conducted during
supervision. District IMCI coordinators reported a com-
mon understanding in the qualitative interviews that the
expectations from the national level were that HSAs
should receive a follow-up visit in their communities
within 6 weeks of training, followed by monthly CCM-
specific supervision visits. However, similar to provision
of drug supplies, implementation of supervision visits
was delayed in most districts. None of the six districts
began CCM supervision visits earlier than 4 months
after the first HSAs were trained, and some HSAs did
not receive any supervision visit for 8 months following
training.Drug supply at one year
Three of the six drugs included in the CCM algorithm
in Malawi–cotrimoxazole, Coartem (Lumefantrine-
artemether, an antimalarial combination therapy),a and
oral rehydration solution (ORS)–are critical for treatment
of the priority childhood illnesses of malaria, pneumonia,
and diarrhea, and are therefore the focus of this analysisb.
Among the 131 HSAs enrolled in the survey, 68.7% [CI:
60.0, 76.5] had all three critical drugs available at their re-
spective CCM clinics at the time of the survey team’s visit
(Table 3). The percentage of HSAs with all three drugs on
the day of the survey team visit ranged from 100% in
Nsanje [CI: 84.5, 100.0] to 52.4% in Kasungu [CI: 29.8,
74.3]. When asked to recall stock outs in the previous
3 months, 46.6% of HSAs reported having a stock out of
any one of the three critical drugs [CI: 37.8, 55.5]. HSAs
reported that Coartem, the only drug which is provided to
HSAs in age-specific dosing, was frequently out of stock
Table 2 Description of the interview and focus
group data
Cadre of worker Type No. participants

















National-level stakeholders In-depth interviews 6
Pharmacy Technicians In-depth interviews 4
Senior HSAs In-depth interviews 2
TOTALS 64
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with 45.8% [CI: 37.1, 54.7] reporting a stock out in the past
3 months. Over 40% of HSAs also reported a stock out of
ORS [42.7%; CI: 34.1, 51.7] but only 10.7% [CI: 6.0, 17.3] of
HSAs reported a Cotrimoxazole stock out in 3 months
(Additional file 1: Table S2).
Among the 111 HSAs who received a resupply of drugs
in the prior 3 months, the majority restocked at the health
center [81%; CI: 72.5, 87.9]. The location of drug resupply
in the three months previous to the survey also varies sig-
nificantly by district. Lilongwe is the only district where
100% of resupplied HSAs received their resupply from aFigure 2 Timing of first trainings, drug distribution, and supervision ihealth center, while 81% of HSAs restocked at the district
hospital in Ntcheu district and 39% of HSAs received drug
stocks from a visiting supervisor in Phalombe (Additional
file 1: Table S2).
Informants reported important challenges in imple-
menting the official drug supply strategy for the CCM
program, which stipulates that HSAs should visit their
nearest health center to request drug stocks (Table 4).
Health center clinicians in several districts reported that
they resisted supplying HSAs with drugs at first because
they had not been informed about the CCM program
and drug supply policies. Additionally, informants at all
levels noted that the health centers themselves experi-
ence periodic drug shortages and stock outs. When drug
stocks at the health center are inadequate, clinicians are
unable or unwilling to provide scarce supplies to HSAs.
According to a health center in-charge, “The only prob-
lem that there is about drug supply [is] we don’t have
drugs here at the health center.” HSAs in some districts
indicated that mistrust had developed between them-
selves and health center clinicians over the sharing of
drug supplies. One HSA stated: “In my opinion I feel
that it is just the selfishness of those medical assistants.
They say ‘we have no drugs’ but they are operating their
services so it is very difficult to say that this problem is
from central medical stores to health facilities.”
Distance was a barrier to drug supply for many HSAs
who reported difficulties traveling to the health center to
collect drugs and in some cases spending their own money
for transport. Transport difficulties exacerbate the chal-
lenge with drug stocks at health centers, as expressed by
one HSA: “When we go to the government facility, most
of the times drugs are out of stock and this is ann two districts.
Table 3 Drug supply, stock outs, and resupply mechanisms
Indicator n All Districts Kasungu Lilongwe Mzimba Nsanje Ntcheu Phalombe p-value
Proportion of HSAs with all critical
drugs for CCM—ACTs, cotrim, and ORS
—on the day of the visit (95% CI)
131 68.7 (60.0, 76.5) 52.4 (29.8, 74.3) 63.6 (40.7, 82.8) 45.5 (24.4, 67.8) 100 (84.5, 100.0)* 90.9 (70.8, 98.9) 59.1 (35.4, 79.3) 0.000
Proportion of HSAs with cotrimoxazole
on the day of the visit (95% CI)
131 96.2 (91.3, 98.7) 85.7 (63.7, 97.0) 95.5 (77.2, 99.9) 85.7 (63.7, 97.0) 100 (84.6, 100.0)* 100 (84.6, 100.0)* 100 (84.6, 100.0)* 0.111
Proportion of HSAs with ACTs (Coartem,
any dose) on the day of the
visit** (95% CI)
131 93.1 (87.4, 96.8) 81.0 (58.1, 94.6) 95.5 (77.2, 99.9) 86.4 (65.1, 97.1) 100 (84.6, 100.0)* 100 (84.6, 100.0)* 95.6 (77.2, 99.9) 0.074
Proportion of HSAs with ORS on the
day of the visit (95% CI)
131 74.0 (65.7, 81.3) 71.4 (47.8, 88.7) 68.2 (45.1, 86.1) 54.5 (32.2, 75.6) 100 (84.6, 100.0)* 90.9 (70.8, 98.9) 59.1 (36.4, 79.3) 0.003
Proportion of HSAs who report a
stockout of any critical drugs in the last
3 months*** (95% CI)
131 46.6 (37.8, 55.5) 66.7 (43.0, 85.4) 50.0 (28.2, 71.8) 50.0 (28.2, 71.8) 0 (0, 15.4)* 40.9 (20.7, 63.6) 72.7 (49.8, 89.2) 0.000
Median days duration of drug stock
outs, any drug (IQR)
131 30 (49.3) 30 (46) 41 (75.8) 60 (82.5) __ 30 (15) 30 (46) __
Proportion of HSAs who received a
resupply of drugs in the last 3 months
(95% CI)
130 85.4 (78.1, 91.0) 95.2 (76.2, 99.9) 85.7 (63.7, 97.0) 68.2 (45.1, 86.1) 86.4 (65.1, 97.1) 95.5 (76.2, 99.9) 81.8 (959.7, 94.8) 0.114
Among HSAs who restocked in the last
3 months, proportion who restocked at
the nearest health center (95% CI)
111 81.1 (72.5, 87.9) 95.0 (75.1, 99.9) 100.0 (81.5, 100)* 93.9 (68.1, 99.8) 84.2 (60.4, 96.6) 28.6 (11.3, 52.2) 94.4 (72.7, 99.9) 0.000
P-values for differences in proportions between districts are calculated using a chi-squared test; P-values for stock out days are calculated using Kruskall-Wallis rank-sum test; *One-sided 97.5% confidence interval;





















Table 4 Challenges and solutions for drug supply and supervision identified by managers and HSAs
Challenges identified by participants Solutions implemented by districts
Drug supply
• Distance from HSA posts to health facilities and lack of transport • Pharmacy technicians deliver drugs to HSAs at their posts
• District managers allow HSAs to collect emergency supplies of
drugs from the district hospital stores
• HSAs working in the catchment areas of health facilities operated by the
Christian Health Association of Malawi (CHAM) are unable to collect drugs
from their nearest facility due to conflicts in user fee policies
• District managers reach an agreement to reimburse CHAM for
drugs supplied to HSAs
• Resistance by health center clinicians to supplying drugs to HSAs when they
are unaware of the new program
• Orientation sessions held for health center clinicians
Supervision
• District-level managers lack time to make supervision visits to HSAs’
communities
• Assistant environmental health officers and Senior HSAs are
included in CCM trainings to enable them to conduct CCM
supervision
• Managers have difficulty securing vehicles and fuel for supervision visits
• Managers lack clear guidelines on what activities should be conducted
during supervision visits
• District managers develop their own supervision checklist, with
assistance of partner organizations
Callaghan-Koru et al. BMC Health Services Research 2013, 13:55 Page 8 of 13
http://www.biomedcentral.com/1472-6963/13/55embarrassment to us because we travel a long distance.”
The challenge of distance was even greater for HSAs
reporting to health centers managed by CHAM, who were
expected to travel to the nearest government health center
to collect drugs which often was further away than the
CHAM facility serving their catchment area.
In several districts, managers took various initiatives to
try to reduce the constraints to drug supply. In some
cases, these practices served to bolster the official drug
supply policy, and in other cases the practices were out-
side the official policy. In support of the official policy, dis-
tricts undertook activities that increased the involvement
in or awareness of the CCM program among health center
staff. Three districts held one-off review or orientation
meetings to inform the health center clinicians about the
CCM program, while another district included the clini-
cians during the initial community sensitization activities
conducted by the district-level managers. Practices that
also facilitated drug supply, but were outside of the official
drug supply policy, included: 1) allowing HSAs to collect
drugs directly from the district hospital; 2) delivering drugs
to the HSAs in their communities; and 3) establishing
agreements with facilities operated by CHAM. These
efforts, although positive, did not show a significant associ-
ation with drug supply or drug stock-outs in this study.
Supervision at one year
Table 5 presents results related to the frequency and
type of supervision received by the sampled HSAs. Over-
all, levels of routine CCM supervision reported by HSAs
were low. Within the period of 3 months prior to the
survey, less than 60% of the HSAs reported receiving
any type of supervision visit [58.6%, CI: 49.6, 67.2], and
only about 40% reported a visit specific to CCM [38.3%;
CI 29.8, 47.3]. Moreover, only 15.6% of HSAs received aCCM supervision visit that included the supervisor ob-
serving the HSA while managing a sick child.
Among the 49 HSAs reporting supervision specific to
CCM in the previous 3 months, IMCI coordinators were
the most frequently-cited cadre conducting the supervi-
sion visit. Some HSAs also reported that Assistant Envir-
onmental Health Officers, IMCI trainers, and pharmacy
technicians provided CCM supervision (data not shown).
The most commonly reported supervisors for the 75
HSAs receiving any supervision visit in the previous
3 months were Environmental Health Officers (30%) and
Senior HSAs (21%). HSAs who received a CCM supervi-
sion visit in their communities reported that, during the
supervisory visit, supervisors checked records (83.7%
percent of visits), corrected the HSA’s work (71.4%),
answered the HSA’s questions (67.3%), and provided
positive feedback (63.3% of visits). Observation of the
HSA performing case management was the least fre-
quently conducted activity by supervisors (36.7% of
supervision visits).
Although the MOH initially advocated monthly super-
vision of each VHC, the survey results demonstrated
that supervision visits were in fact far less frequent.
Every IMCI Coordinator interviewed for this study
acknowledged that their district was unable to meet this
standard of supervision, and the majority considered
monthly supervision to be an unattainable target. Com-
mon supervision challenges cited by manager informants
included supervisors’ busy schedules, lack of transpor-
tation, and the coordination required to undertake su-
pervision in teams (teams often included Pharmacy
Technicians, Environmental Health Officers, and Mal-
aria Coordinators). Districts teams typically visited as
many HSAs as possible during a one- to two-week
period set aside for supervision and rarely spent enough
Table 5 Frequency and type of supervision received by surveyed HSAs
Indicator n* All Districts Kasungu Lilongwe Mzimba Nsanje Ntcheu Phalombe p-value
Proportion of HSAs who received ANY
supervision visit in the last month
(95% CI)
127 27.6 (20.0, 36.2) 47.6 (25.7, 70.2) 19.0 (5.4, 41.9) 54.5 (32.2, 75.6) 22.7 (7.8, 45.4) 9.1 (1.1, 29.2) 10.5 (1.3, 33.1) 0.001
Proportion of HSAs who received ANY
supervision visit in the last 3 months
(95% CI)
128 58.6 (49.6, 67.2) 61.9 (38.4, 81.9) 45.0 (23.1, 68.5) 68.2 (45.1, 86.1) 45.5 (24.4, 67.8) 63.6 (40.7, 82.8) 66.7 (43.0, 85.4) 0.439
Proportion of HSAs who received a
follow-up supervision within
6 weeks of CCM training (95% CI)
128 23.4 (16.4, 31.7) 10.0 (1.2, 31.7) 28.6 (1.3, 52.2) 38.1 (18.1, 61.6) 9.1 (1.1, 29.2) 31.8 (13.9, 54.9) 22.7 (7.8, 45,4) 0.136
Proportion of HSAs who received a
supervision visit specific to CCM in the
previous 1 month (95% CI)
127 15.3 (9.6, 22.6) 14.3 (3.0, 36.3) 5.0 (0.1, 24.9) 36.4 (17.2, 59.3) 13.6 (2.9, 34.9) 22.7 (7.8, 45.4) 0 (0, 16.1)** 0.018
Proportion of HSAs who received a
supervision visit specific to CCM in the
previous 3 months (95% CI)
128 38.3 (29.8, 47.3) 23.8 (8.2, 47.2) 10.0 (1.2, 31.7) 59.1 (36.4, 79.3) 27.2 (10.7, 50.2) 40.9 (20.7, 63.6) 66.7 (43.0, 85.4) 0.001
Proportion of HSAs who received a
CCM supervision in the previous
3 months that included observation
of case management (95% CI)
128 15.6 (9.8, 23.1) 0 (0, 16.1)** 4.5 (0.1, 22.8) 22.7 (7.8, 45.4) 13.6 (2.9, 34.9) 9.1 (1.1, 29.2) 40.9 (20.7, 63.6) 0.002
Proportion of HSAs who discussed their
CCM work with a supervisor at the
health facility (95% CI)
129 44.2 (35.5, 53.2) 61.9 (38.4, 81.9) 23.8 (8.2, 47.2) 50.0 (28.2, 71.8) 18.2 (5.1, 40.3) 42.9 (21.8, 66.0) 68.2 (45.1, 86.1) 0.003
*Among the 131 HSAs included in the sample, observations for these indicators are excluded in the cases where the HSA reports not being in the community during part or all of the study period, responds
“don’t know,” or data was missing from the survey form.
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child. In order to improve supervision frequency, two
districts provided CCM training to routine HSA supervi-
sors, such as Assistant Environmental Health Officers
and Senior HSAs. However, supervision frequency was
not significantly higher in these districts.
Both HSAs and managers agreed that supervision is
valuable for the program, and that the current levels of
supervision are inadequate. However, HSAs desired differ-
ent outcomes from supervision than those expected by
IMCI coordinators, Environmental Health Officers, and
other managers. Program managers generally considered
supervision as an opportunity to correct any mistakes that
HSAs may be making: “for them to do a quality job
throughout, they need to be supervised frequently . . . be-
cause if we leave them without supervision, they may miss
some concepts.” The majority of HSAs welcomed oppor-
tunities for receiving feedback to “know whether [we] are
doing fine or not”, but also expressed a strong desire for
supervisors to help them solve the problems encountered
while operating CCM clinics, particularly in terms of sup-
plies and resource needs. The lack of problem solving dur-
ing supervision visits resulted in frustration among HSAs,
as expressed by one focus group participant:
“When they came to supervise me I told them what I
was lacking in my clinic, but until now there is nothing
that has changed. So I feel like I have not been super-
vised because when you are supervised you expect to see
some change.” (HSA, Focus Group #4)
Job Aid: the Sick Child Recording Form
A key finding that emerged from the qualitative data on
health systems supports for CCM in Malawi is the im-
portance of the job aid developed for the program,
known as the Sick Child Recording Form (SCRF). This
form was adapted in Malawi based on a similar form
developed by WHO as a standard part of IMCI training
and implementation [36]. During the CCM training,
HSAs are taught to conduct assessment following steps
on the form, and to make treatment decisions using the
decision rules included on the form. Informants in the
qualitative study had overwhelmingly positive opinions
about the SCRF. Additionally, in over 90% of sick child
consultations observed during the quality of care survey
study, HSAs made reference to a hard copy of the SCRF
while managing sick children. HSAs reported that they
liked using the SCRF for their CCM work, as the follow-
ing comments by HSAs illustrate:
“I like using the guide line chart because it acts as my
sign post. Whenever I am confused, I consult it to
know where I am lost and then I am in a better
position to do what I am supposed to.”“I should say that the Sick Child Recording Form is
the mwini filimu (the major actor) in this program.”
Managers also considered the SCRF to be important
for the quality of CCM services. One IMCI coordinator
said, “I think HSAs are doing a good job, and basically it
is because they are using the Sick Child Recording
Form.”
Discussion
These results highlight the achievements and challenges
faced by the Malawi MOH and partners as they worked
to rapidly scale up a CCM program to expand access to
curative services for under-fives in a large rural popu-
lation. In addition to the six districts addressed in this case
study, training and implementation was taking place sim-
ultaneously in the majority of Malawi’s districts. The
MOH reported that by 2009, over 1,000 HSAs had
received the six-day CCM training. The SCRF, which
serves as the basis of the training and the job aid for
CCM, was well received by all stakeholders and can be
considered a critical element in the program’s success.
The high levels of support for the program provided by
partner organizations, in terms of technical assistance and
funds for training and supervision, facilitated the rapid
scale up.
These findings also highlight several areas for program
improvement. Early assessments of CBHW programs
from the 1980s indicated the need to plan for and de-
liver necessary health system supports for CBHW pro-
grams [17,19]. However, this evaluation illustrates how
large-scale CCM programs, while expanding access, can
be stymied by the lack of effective health system support.
Inadequacies in the initial implementation plans and
policies presented important barriers to the scale-up of
CCM. Although drug supply strategies integrated well
with existing systems, drug availability remained a chal-
lenge. Additionally, the initial supervision strategy was
not clearly defined or sustainable and district-level pro-
gram managers faced significant barriers in following the
supervision expectations.
This study was nested in an early study of the quality
of care provided by HSAs, so districts included in this
study were chosen based on adequate implementation
strength [37]. Other districts are likely to have weaker
implementation of health system supports during the
same calendar period. That said, the levels of health sys-
tems supports documented in this case study raise con-
cerns about whether Malawi’s CCM program will
achieve the expected increases in coverage levels for
treatment of pneumonia, malaria, and diarrhea.
The health systems support with the most direct im-
pact on effectiveness and coverage of the program is
drug supply. We found that one-third of HSAs did not
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of the visit, and analysis of clinical errors revealed that
over half of mismanaged fever and diarrhea cases were
due to the HSA not having stock of the required treat-
ments [32]. The most important barrier identified by
informants--general drug availability at the restocking
points for CHWs--is statistically correlated with drug
availability among HSAs in Malawi [38]. Health center
drug supply is a large health systems problem in Malawi,
although accurate data measuring the frequency and se-
verity of drug stock outs is limited. The government
cites “lengthy procurement processes, poor specifica-
tions, weak logistical information systems, inadequate
and unpredictable funding for medicines and inadequate
infrastructure,” districts overspending on private sector
drug purchases, and shortage of pharmaceutical staff as
causes of drug stock outs [39]. Solving larger drug supply
problems will take coordinated efforts at institutional re-
form and systems strengthening by many stakeholders
[40]. At the same time, CCM program managers can make
targeted improvements to factors under their control, such
as providing supply chain training to CHWs and managers
and addressing transportation barriers [39].
Just as districts struggled to provide consistent drug
supplies, they were similarly unable to provide regular
supervision with coaching on clinical skills. The focus in
Malawi on the administrative side of supervision (e.g.,
checking records) is consistent with practices reported in
other low-income countries [41]. However, these results
raise concerns about whether the inability of supervisors
to address problems and complaints might reduce HSAs’
motivation, as supportive supervision is important for
morale [42-44]. In fact, HSAs expressed a desire for more
assistance and problem solving from supervisors and for
an expansion of their clinical role, while program man-
agers in Malawi viewed CCM as a limited mandate for
HSAs [34]. Sustaining supervision is a common challenge
for both facility and community-based programs in weak
health systems [41,45]. The initial supervision strategy in
the Malawi CCM program of adding CCM supervision to
the workload of busy facility-based clinicians, which is
common in other programs [43,46,47], may be an unreal-
istic approach for regular and sustained supervision in
many settings. Although CCM programs are often imple-
mented in environments with constrained resources, plan-
ning for resources to implement effective supervision
strategies is essential for scale-up [24]. Supervision ini-
tiatives that include training for supervisors in quality as-
surance, problem solving and coaching may improve
performance and motivation [48-51].
Finally, an important finding of this study is the initiative
and capacity demonstrated by some district health man-
agers to adapt implementation strategies in order to over-
come challenges. Health systems in LICs face considerablechallenges in supporting CCM and other community-
based programs. It is therefore encouraging to see that
dedicated program managers can develop and gain support
for strategies to address some of the barriers that they face,
such as overcoming CCM supervision barriers through the
involvement of HSAs’ routine supervisors. Although none
of the reported strategies were statistically associated with
better drug supply or supervision, this lack of association is
possibly due to the relatively recent implementation of
these strategies at the time of data collection. In the future,
program implementers may consider fostering this type of
decentralized problem solving through adaptive and flex-
ible scale-up strategies [52]. Such efforts could potentially
lead to solutions to local problems, as well as generalizable
strategies that can be learned from and adopted across a
program [52,53].
Conclusions
There is growing concern among public health practi-
tioners that weaknesses in implementation may result in
failure to meet health targets such as the Millennium Devel-
opment Goals [54]. Program coordinators in Malawi indi-
cated that they have already begun to use the results of this
study to target improvements in health systems supports in
order to maximize the impact of CCM towards achieving
their child health goals. In the broader policy context, this
research reinforces the importance of moving beyond a
train-and-deploy strategy towards a broader program devel-
opment approach that includes training as one part of sev-
eral strategic health systems supports required for successful
scale-up. In terms of future research, CCM programming
could benefit greatly from a broad research agenda includ-
ing exploratory work to further elaborate bottlenecks to
supports and quality of CCM as well as controlled trials
testing different quality assurance strategies. A strong CCM
research agenda is critical for ensuring that CBHW pro-
grams meet their potential and are sustained into the future.
Endnotes
a Coartem is supplied in blister packs with separate blis-
ters for doses appropriate for ages 2 to 11 months
(6 doses of 1 tablet, or 1x6) and ages 12 to 48 months
(6 doses of 2 tablets, or 2x6). For the combined indicator of
presence of all critical drugs, HSAs are considered to have
Coartem if they have either the 1x6 or 2x6 blister packs as
in practice these blister packs can be adjusted for either age
group (e.g., providing two 1x6 blister packs to a child over
12 months).
b Paracetamol, antibiotic eye ointment, and zinc are
included in the CCM algorithm but not reported here.
Zinc was not routinely available at the time of our study
and therefore not included in our analysis. Paracetamol
and eye ointment are not included in the priority indica-
tors for treatment of malaria, pneumonia, and/or
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paracetamol, antibiotic eye ointment, and zinc.
Additional file
Additional file 1: Table S1. Demographic and health profile of
included districts. Table S2. Additional drug supply indicators.
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